Stryker ’ s Sage Products invests $3.4m to expand HQ

Stryker (NYSE:SYK) subsidiary Sage Products purchased 27 acres of land in Cary, Ill. for $3.4 million, looking to expand its headquarters in the area, according to a Daily Herald report. Sage makes products for oral care, skin preparation & protection, patient cleaning & hygiene, turning & positioning and heel care. The planned expansion includes an 810,000 square foot addition to the facilities, and is slated to add an additional 350 jobs by 2021, according to the report. Stryker closed its $2.7 billion acquisition of Sage Products in April. The deal for Sage Products, which makes a line of disposable devices designed to reduce so-called “never events” in intensive care and surgical settings, was announced Feb. 1. In August, Sage Products expanded its voluntary worldwide recall to include lots of impregnated cloth topical skin products over contamination issues with the bacteria Burkholderia cepacia, according to an FDA notice. The recall includes Sage Products’ Comfort Shield barrier cloths, incontinence clean-up cloths, M-care meatal cleansing cloths, Comfort Bath cleansing washcloths and .2% chlorhexidine gluconate cloths. The post Stryker’s Sage Products invests $3.4m to expand HQ appeared first on MassDevice.
Source: Mass Device - Category: Medical Equipment Authors: Tags: Business/Financial News Sage Products Stryker Source Type: news

Related Links:

CONCLUSION: Our study seems to reveal TNS is particularly effective on nocturia and urge. Moreover, nocturia and pollakiuria appear to be predictive factors for SNT compliance. Nocturia could be a prominent symptom in SNT's prescription. But studies with more patients should be conducted for obtain better patient selection in TNS. LEVEL OF EVIDENCE: IV. PMID: 30876700 [PubMed - as supplied by publisher]
Source: Progres en Urologie - Category: Urology & Nephrology Tags: Prog Urol Source Type: research
Publication date: Available online 14 March 2019Source: Clinics and Research in Hepatology and GastroenterologyAuthor(s): Charlène Brochard, Marion Chambaz, Alain Ropert, Alexandre Merlini l’Héritier, Timothée Wallenhorst, Guillaume Bouguen, Laurent SiproudhisSummaryBackgroundQuality of life is increasingly seen as important, but remains difficult to assess in patients with functional anorectal complaints.ObjectiveWe aimed to quantify quality of life and to analyse the symptomatic descriptors associated with a poor outcome in patients with faecal incontinence (FI) and/or constipation.MethodsThe c...
Source: Clinics and Research in Hepatology and Gastroenterology - Category: Gastroenterology Source Type: research
We describe BT in four lung transplant candidates and recipients with life-threatening MDR infections, including Pseudomonas aeruginosa (PsA) (n=3) and Burkholderia dolosa (n=1)
Source: The Journal of Heart and Lung Transplantation - Category: Transplant Surgery Authors: Tags: 3 Source Type: research
Left ventricular assist devices (LVAD) are increasingly being used in patients with advanced heart failure. Infections are a major complication associated with LVADs. Our objective was to evaluate the impact of a decolonization protocol with chlorhexidine and intranasal mupirocin ointment on postoperative surgical site infection (SSIs), central line associated bloodstream infection (CLABSI), catheter associated urinary tract infection (CAUTI), and infection related rehospitalization within 90 days of LVAD implantation.
Source: The Journal of Heart and Lung Transplantation - Category: Transplant Surgery Authors: Tags: 531 Source Type: research
We examined the effect of chlorhexidine gluconate (CHG) bathing on the skin microbiota of adult and pediatric patients. We observed no differences in pediatric patients; however, multiple genera of bacteria were observed to be significantly less abundant in the adults bathing with CHG. Further research is needed to determine the long-term impact of CHG use on the skin microbiota.
Source: American Journal of Infection Control - Category: Infectious Diseases Source Type: research
Publication date: July 2019Source: Materials Science and Engineering: C, Volume 100Author(s): François Aubert-Viard, Alejandra Mogrovejo-Valdivia, Nicolas Tabary, Mickael Maton, Feng Chai, Christel Neut, Bernard Martel, Nicolas BlanchemainAbstractThe aim of this work is to design a wound dressing able to release chlorhexidine (CHX) as antiseptic agent, ensuring long-lasting antibacterial efficacy during the healing. The textile nonwoven (polyethylene terephthalate) (PET) of the dressing was first modified by chitosan (CHT) crosslinked with genipin (Gpn). Parameters such as the concentration of reagents (Gpn and CHT)...
Source: Materials Science and Engineering: C - Category: Materials Science Source Type: research
Condition:   Spinal Cord Injuries Intervention:   Device: Dermatome stimulation Sponsor:   Taipei Medical University Active, not recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. Microinnovation: what paper towels have to teach us about medtech How can you double the efficiency of a paper towel? Turns out you don’t need to reformulate or make the paper thicker. Instead, you find a simple concept t...
Source: Mass Device - Category: Medical Devices Authors: Tags: News Well Plus 5 Source Type: news
Stryker (NYSE:SYK) shares slipped today after the medical device company said it’s recalling some of the products sold by subsidiary Sage Products and narrowed its outlook for the rest of the year. Kalamazoo, Mich.-based Stryker paid $2.7 billion in April 2016 for Sage and its line of products designed to prevent so-called “never events.” But it wasn’t long before problems emerged with some of those products; by August Sage had expanded an existing recall of impregnated cloth topical skin products over contamination issues with the bacteria Burkholderia cepacia. That recall covered the Comfort ...
Source: Mass Device - Category: Medical Devices Authors: Tags: Hospital Care Recalls Regulatory/Compliance Sage Products Stryker Source Type: news
Stryker‘s (NYSE:SYK) Sage Products subsidiary is expanding its voluntary worldwide recall to include lots of impregnated cloth topical skin products over contamination issues with the bacteria Burkholderia cepacia, according to an FDA notice. The recall includes Sage Products’ Comfort Shield barrier cloths, incontinence clean-up cloths, M-care meatal cleansing cloths, Comfort Bath cleansing washcloths and .2% chlorhexidine gluconate cloths. Use of the products contaminated with B. cepacia could cause serious infections in patients with compromised immune systems or in hospitalized patients which could be life t...
Source: Mass Device - Category: Medical Equipment Authors: Tags: Food & Drug Administration (FDA) Hospital Care Recalls Sage Products Stryker Source Type: news
More News: Burkholderia | Burkholderia Cepacia | Chlorhexidine | Incontinence | Intensive Care | Jobs | Mergers and Aquisitions | Skin